These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19783381)

  • 41. View from the Nation's Capital. "Off-label" uses of approved drugs: limits on physicians' prescribing behavior.
    Appler WD; McMann GL
    J Clin Psychopharmacol; 1989 Oct; 9(5):368-70. PubMed ID: 2794099
    [No Abstract]   [Full Text] [Related]  

  • 42. [Increased control reduces drug dependence. Balancing benefits and risks is an ethical dilemma].
    Westerholm B
    Lakartidningen; 1994 May; 91(21):2158-9. PubMed ID: 8052003
    [No Abstract]   [Full Text] [Related]  

  • 43. Law enforcement approaches and measures used in countering illicit drug problems in Thailand.
    Yodmani C
    Bull Narc; 1992; 44(1):23-7. PubMed ID: 1477702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 45. Drugs of Dependence Monitoring System: an effective check of the movements of certain drugs in Australia.
    Murdoch DW
    Bull Narc; 1983; 35(4):47-53. PubMed ID: 6563925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug abuse and illicit trafficking in Italy: trends and countermeasures, 1979-1990.
    Marotta E
    Bull Narc; 1992; 44(1):15-22. PubMed ID: 1477701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deregulating mandatory medical prescription.
    Mitchell CN
    Am J Law Med; 1986; 12(2):207-39. PubMed ID: 3327377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
    Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new era in drug regulation?
    Dresser R
    Hastings Cent Rep; 2005; 35(3):10-1. PubMed ID: 16092391
    [No Abstract]   [Full Text] [Related]  

  • 50. Post-marketing management of the use of non-narcotic analgesics.
    Miettinen OS
    Med Toxicol; 1986; 1 Suppl 1():125-7. PubMed ID: 3821427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An underrecognized challenge in evaluating postmarketing drug safety.
    Roden DM
    Circulation; 2005 Jan; 111(3):246-8. PubMed ID: 15668350
    [No Abstract]   [Full Text] [Related]  

  • 52. Administering controlled substances in the home: minimizing the risk of potential diversion.
    Brent NJ
    Home Healthc Nurse; 1989; 7(4):6-7. PubMed ID: 2745132
    [No Abstract]   [Full Text] [Related]  

  • 53. Improving the Clinical Pharmacologic Assessment of Abuse Potential: Part 1: Regulatory Context and Risk Management.
    Sellers EM
    J Clin Psychopharmacol; 2018 Feb; 38(1):11-18. PubMed ID: 29215386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee.
    Arlett P; Portier G; de Lisa R; Blake K; Wathion N; Dogne JM; Spooner A; Raine J; Rasi G
    Nat Rev Drug Discov; 2014 May; 13(5):395-7. PubMed ID: 24751815
    [No Abstract]   [Full Text] [Related]  

  • 55. WHO Expert Committee on Drug Dependence.
    World Health Organization Expert Committee on Drug Dependence
    World Health Organ Tech Rep Ser; 2003; 915():i-v, 1-26, back cover. PubMed ID: 12772439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guidelines and methodological reviews concerning drug abuse liability assessment.
    Balster RL; Bigelow GE
    Drug Alcohol Depend; 2003 Jun; 70(3 Suppl):S13-40. PubMed ID: 12759195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An audience with... Joanna F. Haas.
    Haas JF
    Nat Rev Drug Discov; 2005 Oct; 4(10):806. PubMed ID: 16237844
    [No Abstract]   [Full Text] [Related]  

  • 58. WHO Expert Committee on Drug Dependence.
    World Health Organization
    World Health Organ Tech Rep Ser; 2016; (998):1-34. PubMed ID: 29144065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thought on several problems of clinical revaluation of post-marketing herb research].
    He W; Xie Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(12):1641-3. PubMed ID: 20815225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substance abuse: performance-enhancer use and misuse.
    Moreau T;
    JAAPA; 2010 May; 23(5):18, 21. PubMed ID: 20480867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.